Selected research
Market Structure
Global Erectile Dysfunction Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Erectile Dysfunction market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Erectile Dysfunction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Erectile Dysfunction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Erectile Dysfunction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Erectile Dysfunction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Erectile Dysfunction include Yabang Pharmacy, Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, Teva Pharma, Seoul Pharma, S.K. Chemicals and Petros Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Erectile Dysfunction market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Erectile Dysfunction and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Erectile Dysfunction sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Erectile Dysfunction market size, projected growth trends, production technologies, key applications, and end-use industries.
Erectile Dysfunction Segment by Company
Yabang Pharmacy
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
Teva Pharma
Seoul Pharma
S.K. Chemicals
Petros Pharmaceuticals
Dong-A ST
Erectile Dysfunction Segment by Type
Sildenafil
Tadalafil
Others
Erectile Dysfunction Segment by Application
E-Commerce (B2B)
E-Commerce (B2C)
Retail Pharmacies
Private Clinics
Hospital Pharmacies
Erectile Dysfunction Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erectile Dysfunction market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Erectile Dysfunction and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erectile Dysfunction.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Erectile Dysfunction market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erectile Dysfunction manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erectile Dysfunction in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Erectile Dysfunction in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Sildenafil
- Tadalafil
- Others
Applications
- E-Commerce (B2B)
- E-Commerce (B2C)
- Retail Pharmacies
- Private Clinics
- Hospital Pharmacies
Companies covered
- Yabang Pharmacy
- Eli Lilly
- Pfizer
- Bayer
- BaiYunShan General Factory
- Teva Pharma
- Seoul Pharma
- S.K. Chemicals
- Petros Pharmaceuticals
- Dong-A ST
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Erectile Dysfunction Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Erectile Dysfunction Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Erectile Dysfunction Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Erectile Dysfunction Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Erectile Dysfunction Market Dynamics
- 2.1 Erectile Dysfunction Industry Trends
- 2.2 Erectile Dysfunction Industry Drivers
- 2.3 Erectile Dysfunction Industry Opportunities and Challenges
- 2.4 Erectile Dysfunction Industry Restraints
3 Erectile Dysfunction Market by Manufacturers
- 3.1 Global Erectile Dysfunction Revenue by Manufacturers (2021-2026)
- 3.2 Global Erectile Dysfunction Sales by Manufacturers (2021-2026)
- 3.3 Global Erectile Dysfunction Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Erectile Dysfunction Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Erectile Dysfunction Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Erectile Dysfunction Manufacturers, Product Type & Application
- 3.7 Global Erectile Dysfunction Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Erectile Dysfunction Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Erectile Dysfunction Players Market Share by Revenue in 2025
- 3.8.3 2025 Erectile Dysfunction Tier 1, Tier 2, and Tier 3
4 Erectile Dysfunction Market by Type
- 4.1 Erectile Dysfunction Type Introduction
- 4.1.1 Sildenafil
- 4.1.2 Tadalafil
- 4.1.3 Others
- 4.2 Global Erectile Dysfunction Sales by Type
- 4.2.1 Global Erectile Dysfunction Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Erectile Dysfunction Sales by Type (2021-2032)
- 4.2.3 Global Erectile Dysfunction Sales Market Share by Type (2021-2032)
- 4.3 Global Erectile Dysfunction Revenue by Type
- 4.3.1 Global Erectile Dysfunction Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Erectile Dysfunction Revenue by Type (2021-2032)
- 4.3.3 Global Erectile Dysfunction Revenue Market Share by Type (2021-2032)
5 Erectile Dysfunction Market by Application
- 5.1 Erectile Dysfunction Application Introduction
- 5.1.1 E-Commerce (B2B)
- 5.1.2 E-Commerce (B2C)
- 5.1.3 Retail Pharmacies
- 5.1.4 Private Clinics
- 5.1.5 Hospital Pharmacies
- 5.2 Global Erectile Dysfunction Sales by Application
- 5.2.1 Global Erectile Dysfunction Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Erectile Dysfunction Sales by Application (2021-2032)
- 5.2.3 Global Erectile Dysfunction Sales Market Share by Application (2021-2032)
- 5.3 Global Erectile Dysfunction Revenue by Application
- 5.3.1 Global Erectile Dysfunction Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Erectile Dysfunction Revenue by Application (2021-2032)
- 5.3.3 Global Erectile Dysfunction Revenue Market Share by Application (2021-2032)
6 Global Erectile Dysfunction Sales by Region
- 6.1 Global Erectile Dysfunction Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Erectile Dysfunction Sales by Region (2021-2032)
- 6.2.1 Global Erectile Dysfunction Sales by Region (2021-2026)
- 6.2.2 Global Erectile Dysfunction Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Erectile Dysfunction Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Erectile Dysfunction Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Erectile Dysfunction Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Erectile Dysfunction Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Erectile Dysfunction Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Erectile Dysfunction Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Erectile Dysfunction Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Erectile Dysfunction Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Erectile Dysfunction Revenue by Region
- 7.1 Global Erectile Dysfunction Revenue by Region
- 7.1.1 Global Erectile Dysfunction Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Erectile Dysfunction Revenue by Region (2021-2026)
- 7.1.3 Global Erectile Dysfunction Revenue by Region (2027-2032)
- 7.1.4 Global Erectile Dysfunction Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Erectile Dysfunction Revenue (2021-2032)
- 7.2.2 North America Erectile Dysfunction Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Erectile Dysfunction Revenue (2021-2032)
- 7.3.2 Europe Erectile Dysfunction Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Erectile Dysfunction Revenue (2021-2032)
- 7.4.2 Asia-Pacific Erectile Dysfunction Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Erectile Dysfunction Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Erectile Dysfunction Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yabang Pharmacy
- 8.1.1 Yabang Pharmacy Company Information
- 8.1.2 Yabang Pharmacy Business Overview
- 8.1.3 Yabang Pharmacy Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yabang Pharmacy Erectile Dysfunction Product Portfolio
- 8.1.5 Yabang Pharmacy Recent Developments
- 8.2 Eli Lilly
- 8.2.1 Eli Lilly Company Information
- 8.2.2 Eli Lilly Business Overview
- 8.2.3 Eli Lilly Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Eli Lilly Erectile Dysfunction Product Portfolio
- 8.2.5 Eli Lilly Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Erectile Dysfunction Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 Bayer
- 8.4.1 Bayer Company Information
- 8.4.2 Bayer Business Overview
- 8.4.3 Bayer Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bayer Erectile Dysfunction Product Portfolio
- 8.4.5 Bayer Recent Developments
- 8.5 BaiYunShan General Factory
- 8.5.1 BaiYunShan General Factory Company Information
- 8.5.2 BaiYunShan General Factory Business Overview
- 8.5.3 BaiYunShan General Factory Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 BaiYunShan General Factory Erectile Dysfunction Product Portfolio
- 8.5.5 BaiYunShan General Factory Recent Developments
- 8.6 Teva Pharma
- 8.6.1 Teva Pharma Company Information
- 8.6.2 Teva Pharma Business Overview
- 8.6.3 Teva Pharma Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Teva Pharma Erectile Dysfunction Product Portfolio
- 8.6.5 Teva Pharma Recent Developments
- 8.7 Seoul Pharma
- 8.7.1 Seoul Pharma Company Information
- 8.7.2 Seoul Pharma Business Overview
- 8.7.3 Seoul Pharma Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Seoul Pharma Erectile Dysfunction Product Portfolio
- 8.7.5 Seoul Pharma Recent Developments
- 8.8 S.K. Chemicals
- 8.8.1 S.K. Chemicals Company Information
- 8.8.2 S.K. Chemicals Business Overview
- 8.8.3 S.K. Chemicals Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 S.K. Chemicals Erectile Dysfunction Product Portfolio
- 8.8.5 S.K. Chemicals Recent Developments
- 8.9 Petros Pharmaceuticals
- 8.9.1 Petros Pharmaceuticals Company Information
- 8.9.2 Petros Pharmaceuticals Business Overview
- 8.9.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Petros Pharmaceuticals Erectile Dysfunction Product Portfolio
- 8.9.5 Petros Pharmaceuticals Recent Developments
- 8.10 Dong-A ST
- 8.10.1 Dong-A ST Company Information
- 8.10.2 Dong-A ST Business Overview
- 8.10.3 Dong-A ST Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Dong-A ST Erectile Dysfunction Product Portfolio
- 8.10.5 Dong-A ST Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Erectile Dysfunction Value Chain Analysis
- 9.1.1 Erectile Dysfunction Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Erectile Dysfunction Production Mode & Process
- 9.2 Erectile Dysfunction Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Erectile Dysfunction Distributors
- 9.2.3 Erectile Dysfunction Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst